Article Text
Abstract
Aims The aims of the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) are to support the improvement of care and evidence-based development of therapy of coronary artery disease (CAD).
Interventions To provide users with online interactive reports monitoring the processes of care and outcomes and allowing direct comparisons over time and with other hospitals. National, regional and county-based reports are publicly presented on a yearly basis.
Setting Every hospital (n=74) in Sweden providing the relevant services participates. Launched in 2009 after merging four national registries on CAD.
Population Consecutive acute coronary syndrome (ACS) patients, and patients undergoing coronary angiography/angioplasty or heart surgery. Includes approximately 80 000 new cases each year.
Startpoints On admission in ACS patients, at coronary angiography in patients with stable CAD.
Baseline data 106 variables for patients with ACS, another 75 variables regarding secondary prevention after 12–14 months, 150 variables for patients undergoing coronary angiography/angioplasty, 100 variables for patients undergoing heart surgery.
Data capture Web-based registry with all data registered online directly by the caregiver.
Data quality A monitor visits approximately 20 hospitals each year. In 2007, there was a 96% agreement.
Endpoints and linkages to other data Merged with the National Cause of Death Register, including information about vital status of all Swedish citizens, the National Patient Registry, containing diagnoses at discharge for all hospital stays in Sweden and the National Registry of Drug prescriptions recording all drug prescriptions in Sweden.
Access to data Available for research by application to the SWEDEHEART steering group.
- Public health
Statistics from Altmetric.com
Footnotes
Ulf Stenestrand died on 11 February 2010.
Funding The Swedish Association of Local Authorities and Regions.
Competing interests None.
Provenance and peer review Commissioned; externally peer reviewed.